Kuros Biosciences Launches MagnetOs Bone Graft

Kuros Biosciences commenced full launch of MagnetOsâ„¢ bone graft substitute granules, available as a moldable putty to fill bony defects. In early phased launch, first commercial uses of MagnetOs occurred in 2018 in the U.S. and U.K., in spinal fusion and scoliosis procedures, respectively.

MagnetOs biphasic calcium phosphate graft is designed...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0